References
- Lichtman M A, Liesveld J L. Acute myelogenous leukemia. Williams hematology6th ed., E Beutler, B S Coller, T J Kipps, U Seligsohn. McGraw-Hill, New York 2001; 1047
- Heartin E, Walkinshaw, Clark R E. Successful outcome of pregnancy in chronic myeloid leukemia treated with imatinib (Letter to the editor). Leuk Lymphoma 2004; 45: 1307–1308
- Baer M R, Ozer H, Foon K A. Interferon alpha therapy during pregnancy in chronic myelogenous leukemia and hairy cell leukemia. B J Haematol 1992; 81: 167–169
- Delmer A, Rio B, Bauduer F, Ajchenbaum F, Marie J P, Zittoun R. Pregnancy during myelosuppressive treatment for chronic myelogenous leukaemia [letter]. B J Haematol 1992; 82: 783–784
- Patel M, Dukes I A, Hull J C. Use of hydroxyurea in chronic myeloid leukemia during pregnancy: a case report. Am J Obstetrics Gynecol 1991; 165: 565–566
- Jackson N, Shukri A, Ali K. Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy. B J Haematol 1993; 85: 203–204
- Tertian G, Tchernia G, Papiernik E, Elefant E. Hydroxyurea and pregnancy [letter]. Am J Obstetrics Gynecol 1992; 166: 1868
- Fitzgerald J M, McCann S R. The combination of hydroxyurea and leukapheresis in the treatment of chronic myeloid leukemia in pregnancy. Clin Lab Haematol 1993; 15: 63–65
- Reichel R P, Linkesch W, Schetitska D. Therapy with recombinant interferon alpha-2c during unexpected pregnancy in a patient with chronic myeloid leukemia. B J Haematol 1992; 82: 472
- Fitzgerald D, Rowe J M, Heal J. Leukapheresis for control of chronic myelogenous leukemia during pregnancy. Am J Hematol 1986; 22: 213–218
- Strobl F J, Boelkerding K V, Smith E P. Management of chronic myeloid leukemia during pregnancy with leukapheresis. J Clin Apheresis 1999; 14: 42–44
- Hensley M L, Ford J M. Imatinib treatment: specific issues related to safety, fertility, and pregnancy. Sem Hematol 2003; 40: 21–25
- Novartis Pharmaceuticals Corporation. Gleevec (imatinib mesylate) package insert. Novartis Pharmaceuticals Corporation, East Hanover, NJ 2001